Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercepharma.com

FiercePharma

Get the latest updates from FiercePharma directly as they happen.

Follow now 393 followers

Latest posts

Last updated about 4 hours ago

Pharma's 2026 Super Bowl ads: Novo’s Wegovy pill spot is engagement MVP, while Novartis scores ‘likeability’ touchdown

about 4 hours ago

Novo's star-studded Wegovy pill promotion earned the top spot among the pharma...

Novartis CEO pay soars 30% to $32M following record-breaking 2025 performance

about 5 hours ago

Novartis CEO Vas Narasimhan saw his realized compensation swell by 30% in...

Bristol Myers and Evinova pen global development partnership

about 6 hours ago

Bristol Myers Squibb has signed an agreement to partner with Evinova’s AI-native...

Otsuka awareness campaign urges HCPs to see ‘All of ADHD’

about 9 hours ago

A new campaign from Otsuka aims to educate healthcare professionals about the...

Fresenius Kabi, Phlow ink US onshoring alliance to boost epinephrine injection supply

about 10 hours ago

The agreement will see Phlow as the first drugmaker to produce epinephrine...

Hims retreats from weight loss pill launch as Novo, FDA pressure mounts

about 11 hours ago

Hims & Hers caused a firestorm last week when it revealed that...

Editor’s Corner: Pharma's slack tightening across pipelines, trust

about 18 hours ago

Large drugmakers are facing tighter constraints than in the past, as financial...

Lilly likens relentless work of scientific and athletic progress in Winter Olympics ad

3 days ago

As the 2026 Winter Olympics get underway in Italy this week, Eli...

Roche’s Genentech cut at least 489 jobs last year, new disclosure reveals

3 days ago

On top of 348 known job cuts across the organization last year...

Biogen pins SMA recovery on high-dose Spinraza amid projected 2026 revenue slump

3 days ago

Biogen recorded declining sales for Spinraza in each of the four quarters...

BridgeBio shares slide amid report that Pfizer will withdraw Vyndamax EU patent

3 days ago

The stock price of BridgeBio plunged 15% Thursday on Pfizer's reported decision...

FDA's Makary pledges crackdown on mass marketing of 'illegal copycat drugs' in wake of Hims' Wegovy pill push

3 days ago

“FDA will take swift action against companies mass-marketing illegal copycat drugs, claiming...